Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Zhaoshen Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-8356-3842; OpenAlex author ID A5100733353. Sources: OpenAlex.

Their work

Papers
23 (first author 3, last author 10)
Trials
0
Grants
0
Labs led
1
Collaborators
66
Papers, trials and grants by year

2011: 8 papers · 2012: 4 papers · 2013: 1 paper · 2014: 3 papers · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper

Papers 23

  1. Single-cell RNA sequencing reveals the process of CA19-9 production and dynamics of the immune microenvironment between CA19-9 (+) and CA19-9 (-) PDAC. Co-author DOI 10.1097/cm9.0000000000003130↗
  2. The value of artificial intelligence techniques in predicting pancreatic ductal adenocarcinoma with EUS images: A meta-analysis and systematic review. Last author DOI 10.4103/eus-d-21-00131↗
  3. Transparency of clinical trials in pancreatic cancer: An analysis of availability of trial results from the ClinicalTrials.gov database. Co-author DOI 10.3389/fonc.2022.1026268↗
  4. Research trends of artificial intelligence in pancreatic cancer: a bibliometric analysis. Last author DOI 10.3389/fonc.2022.973999↗
  5. Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1089/cmb.2019.0367↗
  6. Prognostic values of common clinical parameters in advanced pancreatic ductal adenocarcinoma: a large multicenter cohort study of ten years. Co-author PMID 29641971↗
  7. An endoscopic ultrasonography-guided interstitial brachytherapy based special treatment-planning system for unresectable pancreatic cancer. Co-author DOI 10.18632/oncotarget.15763↗
  8. Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Co-author DOI 10.1136/gutjnl-2012-303477↗
  9. Chronic Pancreatitis and Pancreatic Cancer. Last author DOI 10.1159/000365306↗
  10. Phase I trial of M2ES, a novel polyethylene glycosylated recombinant human endostatin, plus gemcitabine in advanced pancreatic cancer. Co-author DOI 10.3892/mco.2014.271↗
  11. Differentiation of pancreatic cancer and chronic pancreatitis using computer-aided diagnosis of endoscopic ultrasound (EUS) images: a diagnostic test. Last author DOI 10.1371/journal.pone.0063820↗
  12. Clinical profiles and long-term outcomes of patients with pancreatic ductal adenocarcinoma and diabetes mellitus. Last author DOI 10.1002/dmrr.1284↗
  13. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China. First author DOI 10.1097/mpa.0b013e31822ca176↗
  14. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer. Last author DOI 10.1245/s10434-011-1968-9↗
  15. Low expression of IGFBP7 is associated with poor outcome of pancreatic ductal adenocarcinoma. Last author DOI 10.1245/s10434-012-2407-2↗
  16. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study. Co-author DOI 10.1016/j.ejca.2010.07.010↗
  17. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Last author DOI 10.1016/j.ejca.2011.03.003↗
  18. Detection of KRAS gene mutations in endoscopic ultrasound-guided fine-needle aspiration biopsy for improving pancreatic cancer diagnosis. Co-author DOI 10.1038/ajg.2011.281↗
  19. Proteomics in pancreatic cancer research. First author DOI 10.1155/2011/365350↗
  20. Incidence of pancreatic cancer in chinese patients with chronic pancreatitis. Co-author DOI 10.1159/000322982↗
  21. Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth. Last author DOI 10.1186/1756-9966-30-35↗
  22. A prediction rule for estimating pancreatic cancer risk in chronic pancreatitis patients with focal pancreatic mass lesions with prior negative EUS-FNA cytolog… Last author DOI 10.3109/00365521.2010.539256↗
  23. Endoscope-assisted brachytherapy for pancreatic cancer: From tumor killing to pain relief and drainage. First author DOI 10.4161/jig.1.1.14596↗

Closest collaborators

The 25 strongest of 66 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haojie Huang · 3 shared papers, 2011–2024 · strength 0.37
  2. Lisi Peng · 2 shared papers, 2023–2024 · strength 0.35
  3. Hua Yin · 2 shared papers, 2022–2023 · strength 0.34
  4. Gang Jin · 2 shared papers, 2012–2024 · strength 0.21
  5. Liang‐Hao Hu · 2 shared papers, 2011–2022 · strength 0.20
  6. Kailian Zheng · 1 shared paper, 2024 · strength 0.18
  7. Deyu Zhang · 1 shared paper, 2024 · strength 0.18
  8. Shiyu Li · 1 shared paper, 2024 · strength 0.18
  9. Dan Wang · 1 shared paper, 2022 · strength 0.17
  10. Ren-Qian Huang · 1 shared paper, 2022 · strength 0.17
  11. Zhendong Jin · 4 shared papers, 2011–2017 · strength 0.17
  12. Deyu Zhang · 1 shared paper, 2023 · strength 0.17
  13. Yiqi Du · 4 shared papers, 2011–2014 · strength 0.17
  14. Qiwen Ben · 5 shared papers, 2011–2012 · strength 0.16
  15. Lisheng Wang · 1 shared paper, 2020 · strength 0.13
  16. Jun Yao · 1 shared paper, 2020 · strength 0.13
  17. Xin Chang · 1 shared paper, 2020 · strength 0.13
  18. Defeng Li · 1 shared paper, 2020 · strength 0.13
  19. Quan-cai Cai · 4 shared papers, 2011–2012 · strength 0.12
  20. Kaixuan Wang · 3 shared papers, 2011–2012 · strength 0.09
  21. Yaozong Yuan · 3 shared papers, 2011–2012 · strength 0.09
  22. Zheng Lu · 2 shared papers, 2011–2017 · strength 0.09
  23. Jun Gao · 3 shared papers, 2011–2012 · strength 0.08
  24. Luo‐Wei Wang · 3 shared papers, 2011 · strength 0.07
  25. Yiliang Bi · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.